BioWorld

May 13, 2002

ViroPharma Prepares To Receive Not Approvable' Picovir Letter

The FDA is not expected to grant ViroPharma Inc. regulatory clearance for its cold medicine that has been criticized for reducing the duration of illness by only one day. (BioWorld Today) Read More

Wyeth Stops Heart Attack Study; Neose Loses Manufacturing Deal

TIGR Deploys Sequence-Based Genomic Analyses To Compare Suspect Anthrax Strain Variants

Isotechnika, Roche To Focus On Transplantation; RA Trial Delayed

Other News To Note

Gliatech Files For Chapter 11 Following Product Setbacks

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...